Kim Nayoun, Lee Hyunji, Shin Junghoon, Nam Young-Sun, Im Keon-Il, Lim Jung-Yeon, Lee Eun-Sol, Kang Young-Nam, Park Se-Ho, Cho Seok-Goo
Laboratory of Immune Regulation, Convergent Research Consortium for Immunologic Disease, Seoul, Korea; Institute for Translational Research and Molecular Imaging, The Catholic University of Korea College of Medicine, Seoul, Korea.
School of Life Sciences and Biotechnology, Korea University, Seoul, Korea.
PLoS One. 2015 May 11;10(5):e0126318. doi: 10.1371/journal.pone.0126318. eCollection 2015.
Establishing mixed chimerism is a promising approach for inducing donor-specific transplant tolerance. The establishment and maintenance of mixed chimerism may enable long-term engraftment of organ transplants while minimizing the use of immunosuppressants. Several protocols for inducing mixed chimerism have been reported; however, the exact mechanism underlying the development of immune tolerance remains to be elucidated. Therefore, understanding the kinetics of engraftment during early post-transplant period may provide insight into establishing long-term mixed chimerism and permanent transplant tolerance. In this study, we intentionally induced allogeneic mixed chimerism using a nonmyeloablative regimen by host natural killer (NK) cell depletion and T cell-depleted bone marrow (BM) grafts in a major histocompatibility complex (MHC)-mismatched murine model and analyzed the kinetics of donor (C57BL/6) and recipient (BALB/c) engraftment in the weeks following transplantation. Donor BM cells were well engrafted and stabilized without graft-versus-host disease (GVHD) as early as one week post-bone marrow transplantation (BMT). Donor-derived thymic T cells were reconstituted four weeks after BMT; however, the emergence of newly developed T cells was more obvious at the periphery as early as two weeks after BMT. Also, the emergence and changes in ratio of recipient- and donor-derived NKT cells and antigen presenting cells (APCs) including dendritic cells (DCs) and B cells were noted after BMT. Here, we report a longitudinal analysis of the development of donor- and recipient-originated hematopoietic cells in various lymphatic tissues of intentionally induced mixed chimerism mouse model during early post-transplant period. Through the understanding of immune reconstitution at early time points after nonmyeloablative BMT, we suggest guidelines on intentionally inducing durable mixed chimerism.
建立混合嵌合体是诱导供体特异性移植耐受的一种有前景的方法。混合嵌合体的建立和维持可能使器官移植长期存活,同时尽量减少免疫抑制剂的使用。已经报道了几种诱导混合嵌合体的方案;然而,免疫耐受发展的具体机制仍有待阐明。因此,了解移植后早期植入的动力学可能有助于建立长期混合嵌合体和永久移植耐受。在本研究中,我们在主要组织相容性复合体(MHC)不匹配的小鼠模型中,通过宿主自然杀伤(NK)细胞清除和T细胞清除的骨髓(BM)移植,使用非清髓方案有意诱导异基因混合嵌合体,并分析了移植后数周内供体(C57BL/6)和受体(BALB/c)植入的动力学。早在骨髓移植(BMT)后一周,供体BM细胞就很好地植入并稳定下来,没有移植物抗宿主病(GVHD)。BMT后四周重建了供体来源的胸腺T细胞;然而,早在BMT后两周,新发育的T细胞在外周就更明显地出现。此外,BMT后还观察到受体和供体来源的NKT细胞以及包括树突状细胞(DCs)和B细胞在内的抗原呈递细胞(APCs)比例的出现和变化。在此,我们报告了对有意诱导的混合嵌合体小鼠模型移植后早期不同淋巴组织中供体和受体来源造血细胞发育的纵向分析。通过了解非清髓性BMT后早期时间点的免疫重建,我们提出了有意诱导持久混合嵌合体的指导原则。